These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 29804232)

  • 1. Early Downregulation of p75
    Suelves N; Miguez A; López-Benito S; Barriga GG; Giralt A; Alvarez-Periel E; Arévalo JC; Alberch J; Ginés S; Brito V
    Mol Neurobiol; 2019 Feb; 56(2):935-953. PubMed ID: 29804232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies.
    Brito V; Puigdellívol M; Giralt A; del Toro D; Alberch J; Ginés S
    Cell Death Dis; 2013 Apr; 4(4):e595. PubMed ID: 23598407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
    Ma Q; Yang J; Li T; Milner TA; Hempstead BL
    Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
    Miguez A; García-Díaz Barriga G; Brito V; Straccia M; Giralt A; Ginés S; Canals JM; Alberch J
    Hum Mol Genet; 2015 Sep; 24(17):4958-70. PubMed ID: 26063761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7,8-dihydroxyflavone ameliorates cognitive and motor deficits in a Huntington's disease mouse model through specific activation of the PLCγ1 pathway.
    García-Díaz Barriga G; Giralt A; Anglada-Huguet M; Gaja-Capdevila N; Orlandi JG; Soriano J; Canals JM; Alberch J
    Hum Mol Genet; 2017 Aug; 26(16):3144-3160. PubMed ID: 28541476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.
    Ginés S; Bosch M; Marco S; Gavaldà N; Díaz-Hernández M; Lucas JJ; Canals JM; Alberch J
    Eur J Neurosci; 2006 Feb; 23(3):649-58. PubMed ID: 16487146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's disease.
    Simmons DA; Belichenko NP; Yang T; Condon C; Monbureau M; Shamloo M; Jing D; Massa SM; Longo FM
    J Neurosci; 2013 Nov; 33(48):18712-27. PubMed ID: 24285878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p75 neurotrophin receptor augments survival signaling in the striatum of pre-symptomatic Q175(WT/HD) mice.
    Wehner AB; Milen AM; Albin RL; Pierchala BA
    Neuroscience; 2016 Jun; 324():297-306. PubMed ID: 26947127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites.
    Liot G; Zala D; Pla P; Mottet G; Piel M; Saudou F
    J Neurosci; 2013 Apr; 33(15):6298-309. PubMed ID: 23575829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotrophin receptor p75(NTR) mediates Huntington's disease-associated synaptic and memory dysfunction.
    Brito V; Giralt A; Enriquez-Barreto L; Puigdellívol M; Suelves N; Zamora-Moratalla A; Ballesteros JJ; Martín ED; Dominguez-Iturza N; Morales M; Alberch J; Ginés S
    J Clin Invest; 2014 Oct; 124(10):4411-28. PubMed ID: 25180603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of striatal 90-kDa ribosomal S6 kinase (Rsk) is a key factor for motor, synaptic and transcription dysfunction in Huntington's disease.
    Anglada-Huguet M; Giralt A; Rué L; Alberch J; Xifró X
    Biochim Biophys Acta; 2016 Jul; 1862(7):1255-66. PubMed ID: 27063456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease.
    Silva A; Naia L; Dominguez A; Ribeiro M; Rodrigues J; Vieira OV; Lessmann V; Rego AC
    Neurodegener Dis; 2015; 15(4):207-18. PubMed ID: 25896770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease.
    Plotkin JL; Day M; Peterson JD; Xie Z; Kress GJ; Rafalovich I; Kondapalli J; Gertler TS; Flajolet M; Greengard P; Stavarache M; Kaplitt MG; Rosinski J; Chan CS; Surmeier DJ
    Neuron; 2014 Jul; 83(1):178-88. PubMed ID: 24991961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.
    Zhao X; Chen XQ; Han E; Hu Y; Paik P; Ding Z; Overman J; Lau AL; Shahmoradian SH; Chiu W; Thompson LM; Wu C; Mobley WC
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5655-64. PubMed ID: 27601642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.
    Canals JM; Pineda JR; Torres-Peraza JF; Bosch M; Martín-Ibañez R; Muñoz MT; Mengod G; Ernfors P; Alberch J
    J Neurosci; 2004 Sep; 24(35):7727-39. PubMed ID: 15342740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease.
    Zuccato C; Marullo M; Conforti P; MacDonald ME; Tartari M; Cattaneo E
    Brain Pathol; 2008 Apr; 18(2):225-38. PubMed ID: 18093249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV1/2-mediated BDNF gene therapy in a transgenic rat model of Huntington's disease.
    Connor B; Sun Y; von Hieber D; Tang SK; Jones KS; Maucksch C
    Gene Ther; 2016 Mar; 23(3):283-95. PubMed ID: 26704721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired TrkB-mediated ERK1/2 activation in huntington disease knock-in striatal cells involves reduced p52/p46 Shc expression.
    Ginés S; Paoletti P; Alberch J
    J Biol Chem; 2010 Jul; 285(28):21537-48. PubMed ID: 20442398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease.
    Jiang M; Peng Q; Liu X; Jin J; Hou Z; Zhang J; Mori S; Ross CA; Ye K; Duan W
    Hum Mol Genet; 2013 Jun; 22(12):2462-70. PubMed ID: 23446639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease.
    Smith GA; Rocha EM; McLean JR; Hayes MA; Izen SC; Isacson O; Hallett PJ
    Hum Mol Genet; 2014 Sep; 23(17):4510-27. PubMed ID: 24728190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.